• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Immunocore Ltd - Articles and news items

IMCgp100

Positive Phase I data for IMCgp100 in metastatic melanoma

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Immunocore has announced positive data from the first in human, Phase I clinical trial of its lead ImmTAC, IMCgp100…

IMCgp100

First patient recruited in IMCgp100 uveal melanoma trial

Industry news / 30 March 2016 / Victoria White

The trial of IMCgp100 will include three Phase I escalation cohorts to determine the optimal dose for the Phase II study, which is expected to start in 2016…

imcgp100

Trial of IMCgp100, durvalumab and tremelimumab in melanoma starts

Industry news / 20 January 2016 / Victoria White

Immunocore has announced the start of the Phase Ib/II combination trial evaluating IMCgp100 with durvalumab and tremelimumab for the treatment of metastatic cutaneous melanoma…

immunocore

Immunocore secures £205 million in Europe’s largest private life sciences financing

Industry news / 16 July 2015 / Victoria White

Immunocore Limited has announced the completion of a £205 million private financing round, allowing it to further accelerate its pipeline of ImmTACs…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +